As biopotential signals are having very small frequency variations tens of Hz and micro to millivolts amplitude in the range. While acquiring biopotential signals from a human body, intrusions occur in the acquisition system. Thus for acquiring noise-free signals, the enhanced Biopotential Acquisition unit having a high gain with an improved common-mode rejection ratio readout front-end is designed. To solve mentioned issues, a Fully Differential Two-Stage OTA is introduced in this paper to achieve high DC gain and high Unity-gain frequency. Operational Transconductance Amplifier operates at ± 0.2 V supply voltage, the bias current of 20µA, and achieves a high gain of 74dB. The design comprises a frequency compensation structure by connecting a capacitor across a high voltage stage and the load capacitor is connected across output by following the relation of CC > 0.22 CL. The proposed high gain stage achieves additional gain with reduced noise of 0.2 mV/\(\sqrt{\text{H}\text{z}}\) with a minimal power consumption of 1.9 nW. The analog readout front-end is executed using 180 nm CMOS Technology and utilizes less power, making it ideal for battery-powered devices in Biopotential Acquisition systems.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.